![]()
Taiwan Semiconductor Manufacturing, Applied Materials, Phillips 66, Forgent Power Solutions, and Astrazeneca are the five Manufacturing stocks to watch today, according to MarketBeat’s stock screener tool. Manufacturing stocks are shares of companies whose primary business is producing physical goods—everything from automobiles and machinery to electronics, chemicals, and packaged consumer products. Investors treat them as typically cyclical, capital‑intensive businesses whose earnings and margins are sensitive to demand cycles, commodity and input costs, supply‑chain disruption, labor and automation trends, and capital expenditure levels. These companies had the highest dollar trading volume of any Manufacturing stocks within the last several days.
Taiwan Semiconductor Manufacturing (TSM)
Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others.
Applied Materials (AMAT)
Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits.
Read Our Latest Research Report on AMAT
Phillips 66 (PSX)
Phillips 66 operates as an energy manufacturing and logistics company in the United States, the United Kingdom, Germany, and internationally. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas.
Read Our Latest Research Report on PSX
Forgent Power Solutions (FPS)
We are a leading designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities. Demand for our products is growing rapidly as (i) companies accelerate investment in data centers to meet the computational requirements for cloud computing and AI, (ii) independent power producers build new generation capacity to satisfy rising electricity demand, (iii) utilities upgrade and expand T&D infrastructure to address rapid load growth and (iv) manufacturers reshore their factories to secure their supply chains and mitigate the impact of tariffs.
Read Our Latest Research Report on FPS
Astrazeneca (AZN)
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases.
Read Our Latest Research Report on AZN
Featured Stories
- MarketBeat’s Top Five Stocks to Own in March 2026
- Blue Owl’s Risk/Reward Profile Is Almost Too Good to Be True
- Commercial Metals Stock Price Poised to Slingshot Higher in Q3
- Russell 2000 Stocks: Too Early or Finally Interesting?
- Can Capital One Prove Itself in 2026?
- The Often-Missed Corner of Healthcare That Wall Street Is Loving
